These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 10147674)

  • 21. Some factors associated with the ultrasonic nebulization of proteins.
    Niven RW; Ip AY; Mittelman S; Prestrelski SJ; Arakawa T
    Pharm Res; 1995 Jan; 12(1):53-9. PubMed ID: 7724488
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aerosolization potential of cyclodextrins--influence of the operating conditions.
    Le VN; Leterme P; Gayot A; Flament MP
    PDA J Pharm Sci Technol; 2006; 60(5):314-22. PubMed ID: 17089700
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of heparin aerosols generated in jet and ultrasonic nebulizers.
    Bendstrup KE; Newhouse MT; Pedersen OF; Jensen JI
    J Aerosol Med; 1999; 12(1):17-25. PubMed ID: 10351126
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhalation of tobramycin in cystic fibrosis. Part 2: optimization of the tobramycin solution for a jet and an ultrasonic nebulizer.
    Le Brun PP; de Boer AH; Gjaltema D; Hagedoorn P; Heijerman HG; Frijlink HW
    Int J Pharm; 1999 Nov; 189(2):215-25. PubMed ID: 10536250
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The conventional ultrasonic nebulizer proved inefficient in nebulizing a suspension.
    Nikander K; Turpeinen M; Wollmer P
    J Aerosol Med; 1999; 12(2):47-53. PubMed ID: 10539706
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Factors influencing the in vitro deposition of tobramycin aerosol: a comparison of an ultrasonic nebulizer and a high-frequency vibrating mesh nebulizer.
    Pedersen KM; Handlos VN; Heslet L; Kristensen HG
    J Aerosol Med; 2006; 19(2):175-83. PubMed ID: 16796542
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Measurement of particle and mass distribution of pentamidine aerosol by ultrasonic and air jet nebulizers.
    Hager J; Gober KH; Löhr JP; Dürr M
    J Aerosol Med; 1992; 5(2):65-79. PubMed ID: 10147685
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PAMAM dendrimers as aerosol drug nanocarriers for pulmonary delivery via nebulization.
    Nasr M; Najlah M; D'Emanuele A; Elhissi A
    Int J Pharm; 2014 Jan; 461(1-2):242-50. PubMed ID: 24275446
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aerosolization of Zn-DTPA Decorporation Agent Using Jet and Ultrasonic Nebulizers.
    Mehri R; Tang W; Matida EA; Lai EPC
    J Aerosol Med Pulm Drug Deliv; 2018 Oct; 31(5):311-320. PubMed ID: 29641361
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antisense oligonucleotides and their technical suitability to nebulization.
    Seidl LL; Moog R; Graeser KA
    Int J Pharm; 2024 Aug; 661():124390. PubMed ID: 38936443
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of a respiratory suspension aerosolized by an air-jet and an ultrasonic nebulizer.
    Tiano SL; Dalby RN
    Pharm Dev Technol; 1996 Oct; 1(3):261-8. PubMed ID: 9552308
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Physical properties of aerosols produced by several jet- and ultrasonic nebulizers.
    Sterk PJ; Plomp A; van de Vate JF; Quanjer PH
    Bull Eur Physiopathol Respir; 1984; 20(1):65-72. PubMed ID: 6704568
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stability of recombinant consensus interferon to air-jet and ultrasonic nebulization.
    Ip AY; Arakawa T; Silvers H; Ransone CM; Niven RW
    J Pharm Sci; 1995 Oct; 84(10):1210-4. PubMed ID: 8801336
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Behavior of nebulizing solutions and suspensions.
    Dahlbäck M
    J Aerosol Med; 1994; 7(Suppl 1):S13-8. PubMed ID: 10147076
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ultrasonic nebulization of cationic lipid-based gene delivery systems for airway administration.
    Pillai R; Petrak K; Blezinger P; Deshpande D; Florack V; Freimark B; Padmabandu G; Rolland A
    Pharm Res; 1998 Nov; 15(11):1743-7. PubMed ID: 9833997
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aerosol production and aerosol droplet size distribution during mechanical ventilation (IPPV) with a new ultrasonic nebulizer.
    Kemming GI; Kreyling W; Habler O; Merkel M; Kleen M; Welte M; Messmer K; Zwissler B
    Eur J Med Res; 1996 Apr; 1(7):321-7. PubMed ID: 9364032
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Compatibility and aerosol characteristics of formoterol fumarate mixed with other nebulizing solutions.
    Akapo S; Gupta J; Martinez E; McCrea C; Ye L; Roach M
    Ann Pharmacother; 2008 Oct; 42(10):1416-24. PubMed ID: 18780805
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aerosols and anti-infectious agents.
    Diot P; Dequin PF; Rivoire B; Gagnadoux F; Faurisson F; Diot E; Boissinot E; Le Pape A; Palmer L; Lemarié E
    J Aerosol Med; 2001; 14(1):55-64. PubMed ID: 11495486
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Jet and ultrasonic nebulization of single chain urokinase plasminogen activator (scu-PA).
    Münster AM; Bendstrup E; Jensen JI; Gram J
    J Aerosol Med; 2000; 13(4):325-33. PubMed ID: 11262439
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The function profile of compressed-air and ultrasonic nebulizers.
    Wu HL; Lin YZ; Wu WF; Huang FY
    Acta Paediatr Taiwan; 2003; 44(5):264-8. PubMed ID: 14964980
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.